(Q44946324)

English

First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine-OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine-OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Leishmania infantum

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Guadalupe Miró

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Leticia Hernández

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Rosa Gálvez

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Rocio Checa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Alba Bello

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Tom Bosschaerts

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Herwig Jansen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Cristina Rupérez

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Anny Fortin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

6 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Parasitology Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

113

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

157-164

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

The leishmaniases as emerging and reemerging zoonoses

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Canine leishmaniasis: a diagnostic and clinical challenge.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Chemotherapy of canine leishmaniosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

The current status of zoonotic leishmaniases and approaches to disease control

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Phlebotomine vectors of the leishmaniases: a review

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Activity of amphotericin B in lipid emulsion in the initial treatment of canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Methods for diagnosis of canine leishmaniasis and immune response to infection

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Diagnosis of canine leishmaniasis: conventional and molecular techniques using different tissues

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Canine leishmaniasis: the key points for qPCR result interpretation.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Canine leishmaniosis--new concepts and insights on an expanding zoonosis: part two.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Canine leishmaniasis: epidemiological risk and the experimental model

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Clinical and experimental advances in treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Treatment of canine Old World visceral leishmaniasis: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Guidelines for treatment of leishmaniasis in dogs

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Development of miltefosine as an oral treatment for leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

LeishVet guidelines for the practical management of canine leishmaniosis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3638-2

21 January 2018

Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24192865

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of Leishmania infantum DNA by fret-based real-time PCR in urine from dogs with natural clinical leishmaniosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24192865

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of parasitological, immunological and molecular methods for the diagnosis of leishmaniasis in dogs with different clinical signs

1 reference

https://pubmed.ncbi.nlm.nih.gov/24192865

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil

1 reference

https://pubmed.ncbi.nlm.nih.gov/24192865

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol

1 reference

https://pubmed.ncbi.nlm.nih.gov/24192865

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24192865

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific serodiagnosis of canine leishmaniasis by indirect immunofluorescence, indirect hemagglutination, and counterimmunoelectrophoresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24192865

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Quantitative PCR in the diagnosis of Leishmania]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24192865

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00436-013-3638-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24192865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44946324&oldid=2207003832"